ClinicalTrials.Veeva

Menu

Orange Juice and Glycaemic Control in Type 2 Diabetes Mellitus

H

Hasselt University

Status

Completed

Conditions

Diabetes Mellitus, Type 2

Treatments

Other: Sugar-sweetened orange-flavoured beverage
Other: Whole orange juice with skin removed
Other: orange juice concentrate

Study type

Interventional

Funder types

Other

Identifiers

NCT04412798
Orange -Juice-001

Details and patient eligibility

About

The evidence on the consumption of 100% orange juice in people with type 2 diabetes is highly variable and largely out-of-date, with a few studies reporting acute negative glycaemic effects when 100% orange juice is drunk with or without a meal. The aim of the project is to study the impact of the intake of a single serving of 100% orange juice on glycaemic control in male patients with pre-existing type 2 diabetes mellitus. In addition, immunological parameters and Alzheimer disease related biomarkers will be assessed to examine the chronic inflammatory state of these patients

Enrollment

15 patients

Sex

All

Ages

25 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Inclusion Criteria: individuals (aged 25-75 years) with up to 8 years of T2DM, according to ADA criteria (Two-hour plasma glucose ≥200 mg/dL (11.1 mmol/L) during OGTT. The test should be performed as described by the WHO, using a glucose load containing the equivalent of 75-g anhydrous glucose dissolved in water; or HbA1c > ≥6.5% (48 mmol/mol)).

Exclusion criteria

  • pregnancy,
  • participants on exogenous insulin therapy,
  • HbA1c >8.5%,
  • BMI <22 or >35 kg/m²,
  • regular smokers (>1 cigarette per day),
  • participants with established cardiovascular disease,
  • neurological disease,
  • cancer,
  • renal disease.
  • Participants who are unwilling to consume any of the standard foods/drinks

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

15 participants in 3 patient groups

group 1
Other group
Description:
orange juice concentrate
Treatment:
Other: orange juice concentrate
Group 2
Other group
Description:
Sugar-sweetened orange-flavoured beverage
Treatment:
Other: Sugar-sweetened orange-flavoured beverage
Group 3
Other group
Description:
Whole orange juice with skin removed
Treatment:
Other: Whole orange juice with skin removed

Trial contacts and locations

1

Loading...

Central trial contact

Kenneth Verboven, dr.; Dominique Hansen, prof. dr.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems